Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives.
about
Macrophage Phenotype in Kidney Injury and RepairImbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological targetMatrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approachesHydroxyfasudil-mediated inhibition of ROCK1 and ROCK2 improves kidney function in rat renal acute ischemia-reperfusion injuryRestoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin.Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesDistinct contributions of TNF receptor 1 and 2 to TNF-induced glomerular inflammation in mice.Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9Protective effects of genetic inhibition of Discoidin Domain Receptor 1 in experimental renal disease1. Pathophysiology and Classification of Kidney DiseasesGenetic analysis of mesangial matrix expansion in aging mice and identification of Far2 as a candidate gene.Endothelial sirtuin 1 deficiency perpetrates nephrosclerosis through downregulation of matrix metalloproteinase-14: relevance to fibrosis of vascular senescence.Urinary collagen degradation products as early markers of progressive renal fibrosisPharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.Resident mesenchymal cells and fibrosis.New renal drug development to face chronic renal disease.Collagen-binding proteins in age-dependent changes in renal collagen turnover: microarray analysis of mRNA expression.Effect of the Direct Renin Inhibitor Aliskiren on Urinary Albumin Excretion in Spontaneous Type 2 Diabetic KK-A (y) Mouse.Integrin α2-deficient mice provide insights into specific functions of collagen receptors in the kidney.Renoprotective action of a matrix metalloproteinase inhibitor in progressive mesangioproliferative nephritis.Urinary matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 biomarkers for predicting renal scar in children with urinary tract infection.Stat3 Controls Tubulointerstitial Communication during CKD.The role of urinary TIMP1 and MMP9 levels in predicting vesicoureteral reflux in neonates with antenatal hydronephrosis.Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy.Early Treatment With Enalapril and Later Renal Injury in Programmed Obese Adult Rats.Role of matrix metalloproteinase-2 in recovery after tubular damage in acute kidney injury in mice.Ethanol consumption increases the expression of endothelial nitric oxide synthase, inducible nitric oxide synthase and metalloproteinases in the rat kidney.La fibrose tubulo-interstitielle rénale
P2860
Q26740474-5CD7DC10-9688-4ED1-8AD1-D9773D693F72Q26864722-971551FE-84AF-46CF-BBBB-95D074FD10F8Q27025492-1BA8BFDF-FEB1-4D79-A4EF-279B0C6B192EQ27316097-C0D36886-E04D-4C56-AB0E-71F0048366E3Q33495583-37BB482F-5966-4668-A27B-F433399549E6Q33733803-7AE81D6E-95EB-4666-BE84-5A0844E3D049Q34837575-89F3F5B3-C4BC-44D9-9E40-CDA763DB59FFQ34906086-174051D4-EDC0-49A9-90E1-ADC1B05F3376Q36583215-A79EB12D-A08E-4B01-9CE8-69A83155376EQ37155224-581A68D1-BD0A-40D5-AF48-FAD849AF2F5EQ37340176-AA6A5900-A6EF-420F-881E-66E1F17BE116Q37524071-09E89E3E-7AC0-4D8C-B1EA-6222DDE2C75AQ37711116-BF7ADA43-60A0-47F4-B4A2-54F5521A92E6Q37978478-AE04CA0F-A25E-4A4B-BB5B-DBE6EA876514Q38065650-828C260E-F5D1-4936-993D-DADBED5D5ADDQ38246640-2FF2A97B-D12E-4815-B662-BEB9E9B40EC6Q38326578-F3F227C6-2807-4715-A7E1-53DE12043F11Q41852636-39505065-0517-4BE2-A9AC-99ACEF91B576Q41953693-34A9D859-A0AA-4630-923E-6AE8C2E0F8B2Q42088862-81A98273-20AC-4336-857A-FBD0EE3C7E33Q46558504-A52A3AA5-043C-4B6C-8F42-2FCD8535E455Q50349533-473E7173-BD0C-4EA9-A1D7-CFE0A9F8B350Q51170863-EE19EE33-28AB-478A-B54F-F0541C6EEE4AQ52603651-D9B1E430-8151-4F59-889B-6353AF5E4340Q52978291-B4DE9F92-F6FE-44BE-B455-1A98790C492FQ53113505-F590D054-EC54-4EC5-84F4-CDB6154D2100Q54335066-FE0DEAF4-42F0-4685-A051-0A2AF1F3D693Q57718617-B5A11639-5637-4140-A174-C12CDA86FFB4
P2860
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Matrix metalloproteinases and ...... ase: therapeutic perspectives.
@en
Matrix metalloproteinases and ...... ase: therapeutic perspectives.
@nl
type
label
Matrix metalloproteinases and ...... ase: therapeutic perspectives.
@en
Matrix metalloproteinases and ...... ase: therapeutic perspectives.
@nl
prefLabel
Matrix metalloproteinases and ...... ase: therapeutic perspectives.
@en
Matrix metalloproteinases and ...... ase: therapeutic perspectives.
@nl
P356
P1433
P1476
Matrix metalloproteinases and ...... ase: therapeutic perspectives.
@en
P2093
Christos Chatziantoniou
Pierre Ronco
P2888
P304
P356
10.1038/KI.2008.349
P407
P577
2008-07-23T00:00:00Z